Noon et al. (2011) have validated p53 as a poor prognostic factor in ccRCC but p53 mutations were only present in ~ 2% of their whole study cohort and 86% of the tumors with p53 overexpression retained wild-type (wt) p53. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.